Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCNN1A | P37088 | 12/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.53 |
| ▸ | THPO | P40225 | 3/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | GMNN | O75496 | 2/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13995446 | 0.95 | SCNN1A (0.51) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL13995455 | 0.95 | SCNN1A (0.51) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL13995443 | 0.85 | SCNN1A (0.50) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL13995451 | 0.85 | SCNN1A (0.55) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL13995419 | 0.84 | KCNH2 (0.53) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL5015580 | 0.84 | ALDH1A1 (0.49) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| Benzamil SCHEMBL5433987 | 0.83 | SCNN1A (0.61) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL12120463 | 0.83 | SCNN1A (0.64) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL12433379 | 0.82 | SCNN1A (0.55) | SCNN1A | |
| SCHEMBL13995449 | 0.81 | SCNN1A (0.48) | SCNN1AALDH1A1NPC1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312212-A1 | Organic Compounds | NOVARTIS AG | 2008-12-18 | — | — | US | disclosed |
| US-20080312212-A1 | Organic Compounds | NOVARTIS AG | 2008-12-18 | — | — | US | disclosed |
| US-20080312212-A1 | Organic Compounds | NOVARTIS AG | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312212-A1 | Organic Compounds | TRPA1, TRPV1, TRPV3 | SCNN1A 21/4885ALDH1A1 1322/4885NPC1 1110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.